ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,319.69
0.83%
Dow Jones
42,635.20
0.00%
Gold vs US Dollar
2,672.845
0.10%
Brent Oil
77.05
0.16%
Bitcoin
93,839.04
0.00%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. INVO BioScience Inc (INVO)

  7. INVO BioScience Inc (INVO) News

INVO BioScience (INVO)

INVO BioScience Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INVO
DateTimeSourceHeadlineSymbolCompany
24/10/202413:00GlobeNewswire Inc.NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular CarcinomaNASDAQ:INVOINVO BioScience Inc
22/10/202416:05Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:INVOINVO BioScience Inc
21/10/202413:00GlobeNewswire Inc.INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA BiosciencesNASDAQ:INVOINVO BioScience Inc
15/10/202413:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
14/10/202413:18GlobeNewswire Inc.INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)NASDAQ:INVOINVO BioScience Inc
01/10/202421:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
20/09/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
18/09/202421:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
14/08/202420:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
14/08/202413:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INVOINVO BioScience Inc
14/08/202413:00GlobeNewswire Inc.INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDANASDAQ:INVOINVO BioScience Inc
21/05/202420:39Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:INVOINVO BioScience Inc
15/05/202420:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
15/05/202420:15GlobeNewswire Inc.INVO Reports Record First Quarter 2024 Financial ResultsNASDAQ:INVOINVO BioScience Inc
06/05/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
17/04/202414:25AllPennyStocks.comMicro Cap Massively Bid Up Before Opening BellNASDAQ:INVOINVO BioScience Inc
16/04/202420:59GlobeNewswire Inc.INVO Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:INVOINVO BioScience Inc
06/02/202415:24Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INVOINVO BioScience Inc
01/02/202414:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
23/01/202413:00GlobeNewswire Inc.NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)NASDAQ:INVOINVO BioScience Inc
17/01/202413:00GlobeNewswire Inc.INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board DirectorsNASDAQ:INVOINVO BioScience Inc
16/01/202422:29Edgar (US Regulatory)Form S-4 - Registration of securities, business combinationsNASDAQ:INVOINVO BioScience Inc
10/01/202421:46Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:INVOINVO BioScience Inc
10/01/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
03/01/202422:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
28/12/202322:04Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:INVOINVO BioScience Inc
28/12/202322:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
13/12/202322:08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INVOINVO BioScience Inc
13/12/202321:53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVOINVO BioScience Inc
11/12/202313:00PR Newswire (US)NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood JournalNASDAQ:INVOINVO BioScience Inc
 Showing the most relevant articles for your search:NASDAQ:INVO

Your Recent History

LSE
BIRD
Blackbird
LSE
PTAL
Petrotal
LSE
ITM
Itm Power
LSE
PANR
Pantheon Resources
LSE
TERN
Tern
LSE
DLAR
De La Rue
LSE
ALBA
Alba Mineral Resources
LSE
MIN
Minoan
LSE
GRL
Goldstone Resources
LSE
WJG
Watkin Jones
LSE
EYE
Eagle Eye Solutions
LSE
RR.
Rolls-royce
LSE
GWMO
Great Western Mining
LSE
ABDN
Abrdn
LSE
SBRY
Sainsbury (j)
LSE
STCM
Steppe Cement
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads